Out Like a Light: Researchers ID Brain's 'Sleep Switch'
Jacqueline Mitchell (BIDMC Communications) (617) 667-7306, firstname.lastname@example.org
OCTOBER 08, 2018
Sleep promoting neurons also tied to regulating body temperature
Two decades ago, Clifford B. Saper, MD/PhD, Chairman of the Department of Neurology at Beth Israel Deaconess Medical Center (BIDMC), and colleagues discovered a set of nerve cells they thought might be the switch that turns the brain off, allowing it to sleep. In a new study published in Nature Communications today, Saper and colleagues demonstrate in mice that that these cells – located in a region of the hypothalamus called the ventrolateral preoptic nucleus (VLPO) – are in fact essential to normal sleep.
“Our paper is the first test of what happens when you activate the VLPO neurons,” said Saper, who is also James Jackson Putnam Professor of Neurology and Neuroscience at Harvard Medical School. “The findings support our original observation that the VLPO cells are essential to normal sleep.”
Working with genetically engineered mice, Saper’s team artificially activated the VLPO neurons using several different tools. In one set of experiments, the scientists activated the neuron cells using a laser light beam to make them fire, a process called optogentics. In another test, the team used a chemical to selectively activate the VLPO neurons. In both cases, activating these cells profoundly drove sleep.
The results confirmed Saper and colleagues’ earlier findings that these neurons are active during sleep and that damage to them causes insomnia – as seen in Saper’s subsequent work with laboratory animals and, in 2014, in older people who have lost cells of the VLPO as part of the natural aging process.
Based on that previous body of work, it came as a surprise when another team of researchers reported just the opposite. In a 2017 publication, experiments stimulating the VLPO neurons woke laboratory animals up. In their current paper, Saper’s team cleared up the seeming contradiction.
“We found that when the VLPO cells are stimulated one to four times per second, they fire each time they are stimulated, resulting in sleep,” Saper said. “But if you stimulate them faster than that, they begin to fail to fire and eventually stop firing altogether. We learned our colleagues in the other lab were stimulating the cells 10 times per second, which was actually shutting them off.”
Additionally, Saper’s team also found that activating the VLPO cells caused a fall in body temperature. Scientists already knew that warm temperatures activate VLPO cells, and that body temperature dips slightly during sleep, when the VLPO neurons are firing.
“We thought that this is why people need to curl up under a warm blanket to get to sleep,” Saper added.
However, with continued activation, body temperature in the mice fell by as much as five or six degrees Celsius. Saper’s team proposed that excessive firing of these same neurons may be responsible for the prolonged sleep and decline in body temperature in animals that hibernate. In follow up, Saper’s team is already looking at the relationship between sleep and body temperature in ongoing studies.
Saper’s co-authors include Daniel Kroeger, Gianna Absi, Celia Gagliardi, Sathyajit S. Bandaru, Loris L. Ferrari, Elda Arrigoni, Thomas E. Scammell and Ramalingam Vetrivelan of the Department of Neurology, Program in Neuroscience and Division of Sleep Medicine, Beth Israel Deaconess Medical Center; Joseph C. Madara of the Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center; and Heike Münzberg, of the Neurobiology of Nutrition and Metabolism, Pennington Biomedical Research Center, Louisiana State University System.
This work was supported by the National Institutes of Health Grants R21-NS074205 and R01-NS088482 (to R.V.), R01-NS091126 (to E.A.), and P01AG09975, P01-HL095491, and R01-NS085477 (to C.B.S.).
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding.
BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Rehabilitation Center and is a research partner of Dana-Farber/Harvard Cancer Center and the Jackson Laboratory. BIDMC is the official hospital of the Boston Red Sox. For more information, visit www.bidmc.org.
BIDMC is part of Beth Israel Lahey Health, a new health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,000 physicians and 35,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.